Hepatitis C-related cirrhosis will be a marginal cause of hospital admissions by 2025-Reference-Cited by-同舟云学术

Hepatitis C-related cirrhosis will be a marginal cause of hospital admissions by 2025

Published:2020-12 Issue:6 Volume:73 Page:1360-1367
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Rodríguez-Tajes Sergio,Pocurull Anna,Castillo Joaquín^ORCID,Casanova Gherzon^ORCID,Vega Laia,Lens Sabela^ORCID,Mariño Zoe,Londoño María-Carlota,Forner Alejandro^ORCID,Torres Ferran^ORCID,Forns Xavier^ORCID

Funder

Instituto de Salud Carlos III

Ministry of Economy and Competitiveness

European Fund of Regional Development

European Commission

Una Manera de Hacer Europa

Secretaria d'Universitats i Recerca del Departament d'Economia i Coneixement

CERCA Programme

Generalitat de Catalunya, Spain

Rio Hortega program

European Social Fund

Catalonian Society of Digestology

Publisher

Elsevier BV

Subject

Hepatology

Reference26 articles.

1. The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients;Sangiovanni;Hepatology,2006

2. Systematic review: outcome of compensated cirrhosis due to chronic hepatitis C infection;Alazawi;Aliment Pharmacol Ther,2010

3. The impact of hepatitis C burden: an evidence-based approach;Younossi;Aliment Pharmacol Ther,2014

4. Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890;Hézode;J Hepatol,2013

5. Sofosbuvir for previously untreated chronic hepatitis C infection;Lawitz;N Engl J Med,2013

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Achieving SVR in patients with hepatitis C-related HCC is associated with an improvement in overall survival: real word data;Hepatoma Research;2024-07-11

2. Role of point-of-care ultrasound (POCUS) in clinical hepatology;Hepatology;2024-07-01

3. Evaluation of the clinical and economic value of sofosbuvir/velpatasvir (SOF/VEL) in patients with chronic hepatitis C in Spain during the last 5 years;Gastroenterología y Hepatología;2024-05

4. The impact of expanded access to direct acting antivirals for Hepatitis C virus on patient outcomes in Canada;PLOS ONE;2023-08-08

5. Immune microenvironment changes of liver cirrhosis: emerging role of mesenchymal stromal cells;Frontiers in Immunology;2023-07-19